Combination therapy using an antiEGFR agent(s) and IGF-1R specific inhibitors

Details for Australian Patent Application No. 2010236818 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Sathyanarayanan, Sriram; Kasibhatla, Shailaja; Winter, Christopher; Chastain, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2010236818

PCT Pub. Number WO2010/120592

Priority 61/169,768 16.04.09 US

Filing date 6 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/120592 Priority application(s): WO2010/120592

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236822-A portable assembly having a subscriber identification module

2010236807-Method for producing solid carbon by reducing carbon oxides